Ipca Laboratories shares rise 0.23% amid volume surge

Shares of Ipca Laboratories were trading with positive momentum in Friday's session, with the stock last traded at Rs 1,315.20 on the NSE, a gain of 0.23% from the previous close. The stock experienced a surge in volume.

On the financial front, Ipca Laboratories has shown steady performance. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,308.85 Crore, compared to Rs 2,092.63 Crore in June 2024. The net profit for the same period was Rs 234.42 Crore, up from Rs 198.98 Crore in the previous year. The EPS stood at Rs 9.19 in June 2025, compared to Rs 7.58 in June 2024.

Here's a more detailed look at Ipca Laboratories' quarterly financial performance:

The company's annual financial performance also reflects consistent growth. The consolidated revenue for the year-ending March 2025 was Rs 8,939.59 Crore, compared to Rs 7,705.04 Crore in March 2024. The net profit for the same period was Rs 787.53 Crore, up from Rs 529.21 Crore in the previous year. The EPS stood at Rs 35.14 in March 2025, compared to Rs 25.82 in March 2024.

Below is a detailed overview of Ipca Laboratories' yearly financial performance:

Ipca Laboratories announced several corporate actions, including relodgement of transfer request for physical shares and newspaper publications. The company announced a final dividend of Rs 2 per share on May 29, 2025, with an effective date of August 5, 2025.

The company has a history of splits and bonus issues. A bonus issue was announced on October 27, 2004, with a 1:1 ratio. The company also executed stock splits, with the most recent one occurring on January 10, 2022, where the face value changed from Rs 2 to Rs 1.

With the stock's last traded price at Rs 1,315.20, Ipca Laboratories is witnessing high volume and positive momentum in today's session.